| FRIDAY, FEBRUARY 7,
2003 |
| 08:30 – 10:30 |
Biology of GnRH Systems in Cancer and Human Reproduction
Chairmen:
M. Motta, Italy
K.J. Catt, USA
|
| |
RECENT
INSIGHTS INTO THE REGULATION OF PULSATILE GNRH SECRETION
K.J. Catt, A.J. Martinez-Fuentes, L. Hu, J. Frattarelli,
L.Z. Krsmanovic, USA |
| |
ROLE
OF MAP-KINASE (MAPK) IN GNRH-STIMULATED TRANSCRIPTIONAL REGULATION
OF GONADOTROPIN SUBUNIT GENES
Z. Naor, Israel |
| |
MECHANISM
OF ANTI-PROLIFERAVITE AND APOPTOTIC EFFECTS OF GNRH AGONISTS
AND ANTAGONISTS IN HORMONE_DEPENDENT CANCER CELL LINES
R. Millar, UK |
| |
GNRH-SYSTEM
IN PROSTATE CANCER AND MELANOMA
M. Motta, Italy |
| |
GNRH-SYSTEMS
IN BREAST AND GYNECOLOGICAL CANCERS
G. Emons, Germany |
| 11:00 – 13:00 |
GnRH Expression, Processing, Localization and Action:
Regulation by Steroid Hormones
Chairmen:
I. Koch, Israel
R. Millar, UK
|
| |
PLASTICITY
IN THE UTILISATION OF GNRH AND GNRH RECEPTOR SUBTYPES IN VERTEBRATES
R. Millar, UK |
| |
THE
PROCESSING OF PRO GNRH
W.C. Wetsel, USA |
| |
IDENTIFICATION
OF ESTROGEN RECEPTOR-B IN THE GNRH NEURONS OF THE RODENT HYPOTHALAMUS
I. Merchenthaler, USA |
| |
DIRECT
GNRH EFFECT ON BREAST CANCER: A NOVEL, PUTATIVE MECHANISM
Y. Koch, Israel |
| 13:00 - 14:30 |
Lunch Break & Exhibition |
13:00 - 14:30
Working Lunch |
MANAGEMENT OF UTERINE FIBROIDS
Moderator:
R.E. Felberbaum, Germany |
14:30 – 16:00
|
GnRH Antagonists: The New Standard in ART Protocols -
Sponsored by Serono
To Be Advised |
16:30 – 18:30
|
Assisted Reproduction: Controversies I
PARALLEL SESSION
Chairmen:
J. Dor, Israel
M.A. Aboulghar, Egypt
|
| |
PROSPECTIVE
DATA CAPTURING, VITAL IN ANSWERING QUESTIONS ON THE STANDARD-LONG-PROTOCOL
VERSUS GNRH-ANTAGONIST- PROTOCOL?
N. van Rooij, L. Happel, Germany
|
| |
GONADOTROPIN-RELEASING
HORMONE ANTAGONISTS VS. AGONISTS IN IN VITRO FERTILIZATION
R. Medved, Slovenia |
| |
CETROTIDE
VS. LUPRON: ASSESSMENT OF CLINICAL OUTCOMES IN ICSI CYCLES
M. Thornton, USA |
| |
A
PROSPECTIVE, RANDOMISED STUDY THAT COMPARE CETROTIDE 3 MG VERSUS
CETROTIDE O.25 MG IN A NON SELECTED POPULATION UNDERGOING IVF
OR ICSI
J. Ohl, France |
| |
TOWARD
A BETTER COST EFFECTIVENESS RATIO IN POOR RESPONDERS : CETRORELIX
3 MG COMBINED WITH CC AND R-HFSH
P. Barriere, France |
| |
RESTRAINED
OVARIAN RESPONSE BY CETRORELIX PROTOCOL IN PCOS
C. Avril, France |
| |
GNRH
ANTAGONIST ASSISTED REPRODUCTION: IS BODY WEIGHT ADJUSTMENT
MANDATORY?
J. Engel, Germany |
| |
GnRH
ANTAGONIST ALLOWS FOR NOVEL APPROACHES IN OVARIAN STIMULATION
FOR IVF
B.C.J.M. Fauser, The Netherlands |
| |
MODIFIED
NATURAL CYCLE IVF: CHARACTERISTICS OF THE LUTEAL PHASE
M.J. Pelinck, The Netherlands |
| |
DIVERSE
ACTIONS OF GNRH AGONIST ON GRANULOSA CELLS AT VARYING FOLLICULAR
STAGES
T. Maruo, Japan |
| |
GNRH
ANTAGONIST IN ASSISTED REPRODUCTION: WILL IT REPLACE THE AGONIST?
M.A. Aboulghar, Egypt |
| 16:30-18:30 |
GnRH Analogues and Hormone Dependent Cancers
PARALLEL SESSION
Chairman:
T. Mardesic, Czech Republic
|
| |
PRESERVING
FERTILITY IN YOUNG WOMEN WITH A MALIGNANCY TREATED WITH A COMBINATION
OF CHEMOTHERAPY AND A GNRH AGONIST
M. Kaplan, The Netherlands |
| |
EFFECTS
OF THE GNRH AGONIST, GOSERELIN ACETATE, ON ESTROGEN AND GNRH
RECEPTOR POSITIVE HUMAN BREAST CANCER CELLS IN VITRO
H.R. Franke, The Netherlands |
| |
PROTOCOL
FOR PREVENTION OF GONADAL DAMAGE DURING CYTOTOXIC THERAPY
T. Mardesic, Czech Republic |
| |
NOVEL
HUMAN CHIMERIC PROTEINS BASED ON GnRH AND PRO-APOPTOTIC PROTEINS
FOR TARGETED THERAPY OF ADENOCARCINOMAS
H. Lorberboum-Galski, Israel |
| |
THE
EFFECT OF COMBINED ANDROGEN BLOCKADE ON THE BONE MINERAL DENSITY
IN METASTATIC PROSTATE CANCER PATIENTS
U. Altug, Turkey |
| 18:30 – 20:00 |
Polycystic Ovary Syndrome - from Pathophysiology to Treatment
PARALLEL SESSION
Chairmen:
K. Diedrich, Germany
O. Ortmann, Germany |
| |
DYSREGULATION
OF GONDATROPIN SECRETION
O. Ortmann, J.M. Weiss, Germany |
| |
TREATMENT
OF PCOS PATIENTS WITH GNRH AGONISTS
K. Diedrich, Germany |
| |
OVARIAN
STIMULATION FOR ART USING GNRH ANTAGONISTS IN PCOS PATIENTS
P. Devroey, E. Kolibianakis, Belgium
|
18:30-19:30 |
Basic Science
PARALLEL SESSION
Chairmen:
A.E. Schindler, Germany
T.L. Scott, USA
|
| |
CELL
CYCLE ARREST IN HUMAN EPITHELIAL OVARIAN CANCER CELL LINE INDUCED
BY GNRH ANTAGONIST CETRORELIX
T. Yano, X. Tang, K. Kugu, Y. Osuga, O. Tsutsumi, Y.
Taketani, Japan |
| |
ANTIPROLIFERATIVE
EFFECTS OF TYPE I AND II GnRH RECEPTORS (GnRH-Rs) EXPRESSED
IN BREAST CANCER CELLS USING RECOMBINANT ADENOVIRUS (Ad)
C.A. McArdle, UK |
| |
GONADOTROPIN
RELEASING HORMONE RECEPTOR EXPRESSION IN PRIMARY BREAST CANCER:COMPARISON
OF IMMUNOHISTOCHEMICAL, RADIOLIGAND AND WESTERN BLOT ANALYSES
A. Paradiso, Italy
|
| |
EXPRESSION
OF GONADOTROPIN-RELEASING HORMONE II (GNRH-II) RECEPTOR IN HUMAN
BREAST, ENDOMETRIAL AND OVARIAN CANCER CELLS AND EFFECTS OF
GNRH-II ON TUMOR CELL PROLIFERATION
C. Grundker, A.R. Gunthert, R.P. Millar, G. Emons, Germany,
Scotland |
